← Evidence map

ArticleCell death & disease2026

RRM1 inhibition sensitizes lung adenocarcinoma to decitabine treatment.

Nan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41748545